Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: The US$320 billion healthcare challenge in ASEAN

Fabian Boegershausen, manager at corporate strategy consulting firm Solidiance, takes a look at rising healthcare costs in ASEAN and provides measurable solutions to overcome future challenges.

Malaysia, Singapore, Indonesia, Philippines, Vietnam, and Thailand (ASEAN 6) will all face an unprecedented rise in healthcare costs over the next decade, putting significant strain on public health budgets.

According to our latest white paper, total healthcare spending in ASEAN 6 countries is estimated to reach US$740 billion by 2025, up from US$420 billion in 2017. An increment of US$320 billion in costs is predicted to incur, nearly doubling today’s spending. Since this implies a massive additional burden, policymakers must take early action to sustain the future of the healthcare industry.

In nearly all ASEAN nations, the growth of cost in healthcare per capita has outpaced the growth in GDP per capita, indicating a gap that will further add an economic burden to the region. Meanwhile, other factors driving future demand are the shift in age demographics and unhealthy lifestyle habits.

A profound population transition to an ageing demographic it happening due to improvement of life expectancy and rising income levels. The elder population (age 65 - above) in southeast Asian nations is expected to grow three times that of the working age population by 2040. The rapid change in population structure will burden society with an increased need for healthcare.

Metabolic risk indicators such as smoking and obesity will also translate into a high prevalence of severe non-communicable diseases. The growth rate for obesity is found to be significantly higher than overweight conditions in ASEAN countries, all of which aggravates the demographic impacts on health.

To add more pressure, regional governments have not especially increased their healthcare spending relative to total budgets and these figures have begun to stagnate or decrease in the past five years. Governments in these nations are unlikely to have sufficient means to meet the increased demand for healthcare with equal increases of healthcare spending.

It is clear the massive rise in healthcare demand poses one of the greatest challenges that ASEAN nations have ever faced, yet here lies also immense opportunity. The key to quality healthcare is to look beyond life expectancy to key drivers of disabilities. This can be done by refocusing healthcare efforts away from an ad-hoc treatment model to a model where the causes of illness are treated early on – in people’s risk behaviour and lifestyles.

One way to lessen the burden of healthcare costs is to generate new sources of healthcare funding. A tax on unhealthy commodity goods, for example, such as salt and sugar can improve health behaviour incentives. The Philippines, for instance, imposed a tax on sugary drinks earlier this year. Governments could also streamline co-payment or broader insurance systems and introduce manageable and effective co-payment fees for public hospitals.

As a significant portion of healthcare costs is a result of personnel expenses partly bound to non-patient facing activities (i.e. administrative and support functions), reducing the need of excessive personnel hired for admin work could free up budgets. Instead, hospitals can replace non-patient facing functions with digitisation to manage patient data, reduce the need for administrative procedures, and remove redundant reviews on drug approvals.

Finally, focusing on effective treatments that avoid future costs must become a key pillar of sustainable healthcare policy. Since patient costs accelerate as they get older, thanks to illness and disability, intervention in early stages or even the full prevention of diseases requires additional spending early on but can greatly reduce cost in the future.

The health demands of ASEAN 6 nations present valuable opportunities for healthcare players such as private hospitals, pharmaceutical companies, and medical device companies. An understanding of the changing health landscape would allow healthcare businesses to advise on the most effective use of their equipment and services and also consult, where possible, on the best practices and potential improvements to efficiency.

The demographic transition will force a rapid development of the geriatric care services market in the ASEAN countries. Next to the immediate medical demand arising from the larger aging population also comes a massive demand for elderly care services. Companies could venture into these related fields, help or even invest in retirement and care homes.

The most significant opportunity of all will be the imminent digitalisation of healthcare, which will raise demand for solutions such as hospital information systems, cloud solutions for medical data, digital tracking of patients and treatments, and the automation of health monitoring.

You can read the white paper “The USD 320 Billion Healthcare Challenge in ASEAN”  here.

Posted on: 30/04/2018 UTC+08:00


News

China Isotope & Radiation, which manufactures diagnostic and therapeutic radiopharmaceuticals products, has launched its HK$1.9 billion (US$247 million) IPO on the Hong Kong Stock Exchange.
Malaysian multinational PRG Holdings has extended the deadline for its M$18.3 million (US$4.6 million) acquisition of O&G focused private medical services provider Roopi Medical Centre.
Hong Kong-listed WuXi Biologics, a subsidiary of WuXi PharmaTech, has started the construction of an integrated biologics conjugate solution centre in Wuxi city.
RHT Health Trust, the first business trust listed on the Singapore stock exchange with a portfolio comprising healthcare assets in India, has confirmed that it has received all outstanding amounts due from India’s Fortis Healthcare for the past financial year.
Shares in Ramsay Health Care, Australia’s largest private hospital operator, slumped today after the group cut earnings guidance. It flagged up “onerous lease provisions” and asset writedowns on a number of its hospitals in the UK.
Following Monday’s 5.9 magnitude earthquake which struck Osaka, Parkway Life REIT, which is owned by IHH Healthcare, has confirmed that its Japan asset managers, operators and residents at its Japan healthcare facilities are accounted for with no reported injuries.
Singapore-listed property developer Perennial Real Estate has incorporated a new subsidiary in China. Perennial (Shanghai) Health Management will be involved in the management of its healthcare business in Shanghai.
Yestar Aesthetic Medical Group, the second largest private aesthetic medical institution group in China, is planning an IPO on Hong Kong’s mainboard. CICC is sole sponsor to the deal.



Analysis

Aon’s inaugural Asia Healthcare Trends Report 2017/18 shows that although Hong Kong has a lower medical inflation rate than the average in APAC, it is the highest in Greater China.
Out of date and unsecure fax machines are still being used to share patient information between healthcare providers in Australia. Not only do fax machines cause frustration for healthcare providers trying to communicate with each other, they can also cause patient harm.
Health and well-being programmes are fragmented and do not meet the needs of stressed Asia workforces, finds Willis Towers Watson. By and large, employers in Asia still miss the mark when it comes to their health and well-being benefits, with many employees feeling that their needs are not met, according to research from the global advisory, broking and solutions company.
According to a survey of biopharma companies by L.E.K. Consulting, the majority of firms from Western Europe or the US are interested in China, specifically those at Phase 2 or later development.
Sara Jost, global healthcare industry lead at BlackBerry, explains that putting the systems and procedures in place to deliver a healthy and secure digital healthcare system will protect patient health information and support medical innovation.
Joseph Soon, global digital director at Bupa, explains why industry players must stay agile in the market and act fast to take every opportunity the digital age has to offer.
The Asia-Pacific (APAC) healthcare industry is undergoing rapid transformation with a dramatic shift in consumer behaviour and expectations, opening up growth opportunities across diagnostics, regenerative medicine, medical tourism and digital health.
Tan Chorh Chuan, executive director at the Office for Healthcare Transformation and chief health scientist at the Ministry of Health in Singapore, explains why population health improvement has to become a crucial area of focus.
my images

Podcasts

HealthInvestor Asia twitter feed